Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction

The wearable cardioverter–defibrillator (WCD) is used in patients with newly diagnosed heart failure and reduced ejection fraction (HFrEF). In addition to arrhythmic events, the WCD provides near-continuous telemetric heart failure monitoring. The purpose of this study was to evaluate the clinical r...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Henrike Aenne Katrin Hillmann, Stephan Hohmann, Johanna Mueller-Leisse, Christos Zormpas, Jörg Eiringhaus, Johann Bauersachs, Christian Veltmann, David Duncker
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2021-11-01
Ráidu:	Sensors
Fáttát:	wearable cardioverter–defibrillator sudden cardiac death heart failure heart failure monitoring
Liŋkkat:	https://www.mdpi.com/1424-8220/21/23/7798
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!